Employers Struggle To Cope With the Rising Use of Biologics: Tradeoffs in cost sharing or higher deductibles could derail treatment and decrease the value of healthcare spending.

Abstract

Employers have tried everything from uptiering to tighter utilization management in trying to mitigate the high cost of biologics. They now hope that biosimilars may offer some relief. But there's another option - one they should take a hard look at.